MKI67 and neoplasm: Currently, this neoplasia is classified into distinct subtypes based on tumor staging/grading and the expression of the estrogen receptor (ESR1), progesterone receptor (PgR), human epidermal growth factor receptor 2 (HER2), and the proliferation marker Ki-67 [2].